News

  • AIPLA's Women in IP Law Committee Hosts Global Networking Event

    May 1, 2023

    On April 27, 2023, AIPLA's Women in IP Law Committee hosted the 2023 Women in IP Law Global Networking Event. The theme for this year’s event was: Owning Your Voice, as an encouragement for women to fill up their space and speak up their role in the profession. Over 60 cities worldwide participated in the event, and most locations hosted live in-person meetings.
  • USPTOHouseLetter-12-1-21-logo AIPLA Comments on Federal Trade Commission Non-Compete Clause

    April 21, 2023

    Arlington, VA. April 21, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the Federal Trade Commission in response to their published notice on Non-Compete Clause Rulemaking, 88 FR 3482, on January 19, 2023. The proposed rule would effectively ban the use of non-competes, with few exceptions.
  • European Commission AIPLA Comments on the Latest Amendments to the EPO Guidelines for Examination

    April 3, 2023

    Arlington, VA. April 3, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the European Patent Office (EPO) on the latest amendments to their Guidelines for Examination.
  • negative-space-man-browsing-tablet-ipad-computer-coffee-touch-finger-work-desk-office-linkedin-400 AIPLA Files an Amicus Brief with the Court of Appeals of Virginia in Pegasystems Inc. v. Appian Corporation

    March 6, 2023

    Arlington, VA. March 6, 2023 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Court of Appeals of Virginia in Pegasystems Inc. v. Appian Corporation, an appeal arising from a $2.1 billion verdict and resulting judgment in a trade secret misappropriation case brought by Appian against Pegasystems.
  • USPTO Issues Final Rule on Claim Construction Standard AIPLA Comments on Joint USPTO-FDA Collaboration Initiatives

    February 28, 2023

    Arlington, VA. February 28, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office (USPTO) in response to the USPTO’s Request for Comments on Joint USPTO-FDA Collaboration Initiatives.